Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2008 2
2009 1
2010 1
2011 1
2012 2
2013 8
2014 5
2015 6
2016 3
2017 4
2018 7
2019 11
2020 16
2021 16
2022 27
2023 24
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for ratio e[au]
Your search for Ramió E[au] retrieved no results
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.
Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, Yu J, Bu Z, Chen L, Du Y, Wang X, Wu A, Li G, Su X, Xiao G, Cui M, Wu D, Chen L, Wu X, Zhou Y, Zhang L, Dang C, He Y, Zhang Z, Sun Y, Li Y, Chen H, Bai Y, Qi C, Yu P, Zhu G, Suo J, Jia B, Li L, Huang C, Li F, Ye Y, Xu H, Wang X, Yuan Y, E JY, Ying X, Yao C, Shen L, Ji J; RESOLVE study group. Zhang X, et al. Among authors: e jy. Lancet Oncol. 2021 Aug;22(8):1081-1092. doi: 10.1016/S1470-2045(21)00297-7. Epub 2021 Jul 9. Lancet Oncol. 2021. PMID: 34252374 Clinical Trial.
The primary endpoint, assessed in the modified intention-to-treat population, 3-year disease-free survival to assess the superiority of perioperative-SOX compared with adjuvant-SOX and the non-inferiority (hazard ratio non-inferiority margin of 1.33) of adjuvant-SOX compar …
The primary endpoint, assessed in the modified intention-to-treat population, 3-year disease-free survival to assess the superiority of peri …
Long COVID occurrence in COVID-19 survivors.
Sugiyama A, Miwata K, Kitahara Y, Okimoto M, Abe K, E B, Ouoba S, Akita T, Tanimine N, Ohdan H, Kubo T, Nagasawa A, Nakanishi T, Takafuta T, Tanaka J. Sugiyama A, et al. Among authors: e b. Sci Rep. 2022 Apr 11;12(1):6039. doi: 10.1038/s41598-022-10051-z. Sci Rep. 2022. PMID: 35411017 Free PMC article.
Multivariate analysis showed that age was an independent risk factor for sequelae (adjusted odds ratios [AOR] for 60 years vs. < 40 years 3.63, p = 0.0165). Possible psychological distress was noted in 30.7% (17.9% of males and 45.0% of females). ...

Multivariate analysis showed that age was an independent risk factor for sequelae (adjusted odds ratios [AOR] for 60 years vs. < 4

Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis.
Guo K, Zhou L, Shang X, Yang C, E F, Wang Y, Xu M, Wu Y, Li Y, Li M, Yang K, Li X. Guo K, et al. Among authors: e f. Drug Alcohol Depend. 2022 Dec 1;241:109672. doi: 10.1016/j.drugalcdep.2022.109672. Epub 2022 Oct 23. Drug Alcohol Depend. 2022. PMID: 36332593 Review.
Furthermore, compared to the varenicline, evident abstinence superiority was found in varenicline + bupropion (odds ratio = 1.49, 95% confidence interval [1.02, 2.18]). Finally, the surface under the cumulative ranking curve value indicated that varenicline + bupropion has …
Furthermore, compared to the varenicline, evident abstinence superiority was found in varenicline + bupropion (odds ratio = 1.49, 95% …
Effectiveness and Safety of Varenicline for Smoking Cessation: An Overview and Meta-analysis.
Shang X, E F, Guo K, Yang C, Zhou L, Wu Y, Yang K, Li X. Shang X, et al. Among authors: e f. J Addict Med. 2023 Sep-Oct 01;17(5):536-543. doi: 10.1097/ADM.0000000000001171. Epub 2023 May 3. J Addict Med. 2023. PMID: 37788606 Review.
The meta-analysis results showed that, compared with the placebo, varenicline significantly increased the odds of smoking cessation (odds ratio = 2.54, 95% confidence interval = 2.20-2.94, P < 0.05, moderate quality). ...
The meta-analysis results showed that, compared with the placebo, varenicline significantly increased the odds of smoking cessation (odds …
The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study.
Li C, Wu J, Jiang L, Zhang L, Huang J, Tian Y, Zhao Y, Liu X, Xia L, E H, Gao P, Hou L, Yang M, Ma M, Su C, Zhang H, Chen H, She Y, Xie D, Luo Q, Chen C. Li C, et al. Among authors: e h. Cancer Immunol Immunother. 2023 Mar;72(3):783-794. doi: 10.1007/s00262-022-03262-w. Epub 2022 Sep 3. Cancer Immunol Immunother. 2023. PMID: 36056951
METHODS: In this multi-center retrospective study, 122 and 92 stage I-IIIB NSCLC patients from six hospitals who received neoadjuvant chemoimmunotherapy followed by surgery were included in the discovery and external validation cohort, respectively. Baseline and on-treatment neut …
METHODS: In this multi-center retrospective study, 122 and 92 stage I-IIIB NSCLC patients from six hospitals who received neoadjuvant chemoi …
Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: A meta-analysis.
Zhang Z, Cao Y, Tao Y, E M, Tang J, Liu Y, Li F. Zhang Z, et al. Among authors: e m. Diabetes Res Clin Pract. 2020 Jan;159:107990. doi: 10.1016/j.diabres.2019.107990. Epub 2019 Dec 19. Diabetes Res Clin Pract. 2020. PMID: 31866530 Review.
In comparing sulfonylurea users with patients who had not taken sulfonylurea, the pooled risk ratio for developing fracture was 1.14 (95% confifidence interval, 1.08-1.19). In subgroup analyses, the pooled risk ratio of bone fracture in patients receiving sulfonylur …
In comparing sulfonylurea users with patients who had not taken sulfonylurea, the pooled risk ratio for developing fracture was 1.14 …
Association between alcohol consumption and amyotrophic lateral sclerosis: a meta-analysis of five observational studies.
E M, Yu S, Dou J, Jin W, Cai X, Mao Y, Zhu D, Yang R. E M, et al. Neurol Sci. 2016 Aug;37(8):1203-8. doi: 10.1007/s10072-016-2575-0. Epub 2016 Apr 21. Neurol Sci. 2016. PMID: 27103621 Review.
Five articles, including one cohort study and seven case-control studies, and a total of 431,943 participants, were identified. The odds ratio for the association between alcohol consumption and amyotrophic lateral sclerosis was 0.57 (95 % confidence interval 0.51-0.64). . …
Five articles, including one cohort study and seven case-control studies, and a total of 431,943 participants, were identified. The odds …
A meta-analysis of passive smoking and risk of developing Type 2 Diabetes Mellitus.
Wei X, E M, Yu S. Wei X, et al. Among authors: e m. Diabetes Res Clin Pract. 2015 Jan;107(1):9-14. doi: 10.1016/j.diabres.2014.09.019. Epub 2014 Oct 14. Diabetes Res Clin Pract. 2015. PMID: 25488377 Review.
The Newcastle-Ottawa Scale (NOS) was used to assess the quality of included studies. The odds ratio (ORs) for the association was determined using a fix-effects model. ...
The Newcastle-Ottawa Scale (NOS) was used to assess the quality of included studies. The odds ratio (ORs) for the association was det …
Population-based study of environmental lead exposure and hearing loss: a systematic review and meta-analysis.
Yin JZ, E M, Chao H. Yin JZ, et al. Among authors: e m. Public Health. 2021 Aug;197:63-67. doi: 10.1016/j.puhe.2021.06.009. Epub 2021 Aug 2. Public Health. 2021. PMID: 34352681 Review.
RESULTS: Environmental lead exposure was significantly and substantially associated with hearing loss (combined odds ratio [OR] 1.42; 95% confidence interval [CI] 1.22-1.67) with mild heterogeneity (I(2) = 47.0%, P = 0.049). ...
RESULTS: Environmental lead exposure was significantly and substantially associated with hearing loss (combined odds ratio [OR] 1.42; …
Sulfonylureas use and fractures risk in elderly patients with type 2 diabetes mellitus: a meta-analysis study.
Tao Y, E M, Shi J, Zhang Z. Tao Y, et al. Among authors: e m. Aging Clin Exp Res. 2021 Aug;33(8):2133-2139. doi: 10.1007/s40520-020-01736-4. Epub 2020 Oct 26. Aging Clin Exp Res. 2021. PMID: 33104983 Review.
RESULT: A total of 7 studies involving 464,121 individuals were included in our meta-analysis. The pooled risk ratio for developing fracture in sulfonylurea users with type 2 diabetes ( 65 years old) was 1.26 (95% CI 1.15-1.39). ...
RESULT: A total of 7 studies involving 464,121 individuals were included in our meta-analysis. The pooled risk ratio for developing f …
122 results